SCHEMBL7747548

SCHEMBL7747548

Cc1ccc(S(=O)(=O)ONC(=N)NN=Cc2cccc(O)c2O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.48
MAPT P10636 5/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
HTT P42858 2/20 0.48
NOX4 Q9NPH5 1/20 0.48
KDM4E B2RXH2 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
GAA P10253 1/20 0.46
MPI P34949 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ALDH1A1 P00352 1/20 0.46
RAB9A P51151 1/20 0.46
KDM1A O60341 1/20 0.43
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
OXTR P30559 2/20 0.40
AVPR1A P37288 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7748732 0.83 NCOA1 (0.49) LMNAMAPTMEN1KMT2AHTT
SCHEMBL2065807 0.81 NOX4 (0.49) LMNAMAPTMEN1KMT2AHTT
SCHEMBL2065810 0.81 NOX4 (0.49) LMNAMAPTMEN1KMT2AHTT
SCHEMBL2065811 0.80 MAPT (0.51) LMNAMAPTMEN1KMT2AHTT
SCHEMBL7747541 0.80 LMNA (0.51) LMNAMAPTMEN1KMT2AHTT
SCHEMBL7747544 0.80 LMNA (0.51) LMNAMAPTMEN1KMT2AHTT
SCHEMBL7748726 0.78 ALDH1A1 (0.49) LMNAMAPTMEN1KMT2AHTT
SCHEMBL7743109 0.77 MAPT (0.51) LMNAMAPTMEN1KMT2AHTT
SCHEMBL7750407 0.76 KMT2A (0.58) LMNAMAPTMEN1KMT2AHTT
SCHEMBL16224301 0.75 NOX4 (0.70) LMNAMAPTMEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001025192-A1 GUANIDINE DERIVATIVES AND THEIR USE IN THE PRODUCTION OF A MEDICAMENT FOR BLOCKING XANTHINE OXIDASE/DEHYDROGENASE MELACURE THERAPEUTICS AB (SE) 2001-04-12 WO disclosed